<link rel='stylesheet' href='https//fonts.googleapis.com/css?family=Roboto:400,500,700,400italic|Material+Icons'>
Open Search
VRTX
Vertex Pharmaceuticals
$
()


  • Vertex announces CHMP recommendation for Kaftrio label extension

    9/15/2023 - 08:54am
  • Vertex appoints Atkinson EVP Chief Technical Operations Officer

    8/29/2023 - 09:06am
  • Vertex Pharmaceuticals price target raised to $315 from $312 at Canaccord

    8/7/2023 - 06:29am
  • Vertex: VX-548 preclinical studies, Phase 2, proof-of-concept results published

    8/3/2023 - 09:09am
  • Vertex Pharmaceuticals price target raised to $425 from $410 at Wells Fargo

    8/2/2023 - 09:18am
  • Vertex Pharmaceuticals price target raised to $370 from $360 at TD Cowen

    8/2/2023 - 07:34am
  • Vertex Pharmaceuticals price target raised to $390 from $380 at Bernstein

    8/2/2023 - 06:24am
  • Vertex Pharmaceuticals price target raised to $399 from $384 at Barclays

    8/2/2023 - 05:47am
  • Vertex Pharmaceuticals raises FY23 CF product revenue to $9.7B-$9.8B

    8/1/2023 - 16:05pm
  • Vertex Pharmaceuticals reports Q2 EPS $3.52, consensus $3.88

    8/1/2023 - 16:04pm
  • Vertex Pharmaceuticals price target raised to $400 from $350 at BofA

    7/21/2023 - 08:59am
  • Vertex Pharmaceuticals granted approval for label extension of Orkambi

    7/5/2023 - 05:09am
  • Vertex Pharmaceuticals price target raised to $340 from $305 at Morgan Stanley

    7/3/2023 - 07:52am
  • Sigilon Therapeutics downgraded to Neutral from Buy at BTIG

    6/29/2023 - 16:29pm
  • Vertex Pharmaceuticals price target raised to $360 from $350 at TD Cowen

    6/28/2023 - 07:34am
dynamic_feed Breaking News